Multiple sclerosis susceptibility alleles in African Americans. - Wikidata - awgldk - TriplyDB

Multiple sclerosis susceptibility alleles in African Americans.

Multiple sclerosis susceptibility alleles in African Americans.

http://www.wikidata.org/entity/Q33892035

about

The Evi5 family in cellular physiology and pathology Genome-wide association study of severity in multiple sclerosis.Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab Polymorphisms of CLEC16A region and autoimmune thyroid diseases.Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene CD6 as a therapeutic target in autoimmune diseases: successes and challenges.Inherited variants in regulatory T cell genes and outcome of ovarian cancer.Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian Population Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.Association of multiple sclerosis susceptibility variants and early attack location in the CNS Tumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian population Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential.RGS1 regulates myeloid cell accumulation in atherosclerosis and aortic aneurysm rupture through altered chemokine signalling.Response to interferon-Beta treatment in afro-caribbeans with multiple sclerosis.CD6 attenuates early and late signaling events, setting thresholds for T-cell activation Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.Association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with multiple sclerosis risk: A meta-analysis Immunological evaluation of rheumatoid arthritis patients treated with itolizumab.Genetic risk variants in African Americans with multiple sclerosis A clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A.Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.R4 Regulator of G Protein Signaling (RGS) Proteins in Inflammation and Immunity Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.Disability and progression in Afro-descendant patients with multiple sclerosis.Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from Interferons for Cytokine Responses.RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.Interleukin-17- and interleukin-22-secreting myelin-specific CD4(+) T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients.A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome Replication of top markers of a genome-wide association study in multiple sclerosis in Spain.Correlation of serum cytokines, chemokines, growth factors and enzymes with periodontal disease parameters.Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease

P2860

Q27013381-821CC158-77A3-4807-B40C-4F7756B2251A Q29417054-40377D38-952A-49AE-91DE-C6311D8DED20 Q33573621-CDDD5FEE-DFBF-4803-BC68-5976D71D928B Q33785016-26681465-7B47-4AF3-98C2-7B00172A3472 Q34284850-0817361A-40B5-49AD-B779-29359A3C8265 Q34337963-28008FA5-F628-4A92-9782-81DA8F2A0157 Q34575290-98ED1A1B-F57A-45E3-A375-BCCCC4088B5F Q34979385-FD61D25C-54FE-4DB8-BAC8-75AC24BCD377 Q35018274-03366E3C-A185-4861-B83C-BEF0E24A26AE Q35018315-FA1A17D5-ECA4-4B22-9A8E-170EF23E5518 Q35124012-E0F3F32B-0EFC-4BB0-89A1-36D0CC2BB316 Q35195555-79CABBB3-97A5-4F0D-89E8-7AE27C912522 Q35218126-60F0F425-A0B6-477A-84FE-9126706E1816 Q35367901-FFE46B88-665C-4387-B258-486AED9DB7D3 Q35818957-12D917A5-3BEF-4C06-A94A-074160265A13 Q36438926-9305D89A-5C43-44D8-82A6-6F5F734A1EC2 Q36440208-BF43A6FF-4B59-4A10-BE4D-8D7ED54595A3 Q37005355-950C6B03-A03E-4048-8E8D-94108DF2DC2C Q37138277-4ADD22DF-6DEC-4B78-B14D-B00FDB2F828E Q37163271-72FEB939-0761-4F3D-B18F-D838D45911DE Q37390483-93A37556-7044-4F3C-A253-541C78FE938A Q37990779-F4760706-3E1C-489D-B408-C1837258E5E3 Q38084534-06A43640-DE49-4E34-A957-C72558109CBC Q38140023-7A4DC68D-36D8-4B43-94CA-865EA5B6E4A2 Q38644453-1831F533-9CFB-4680-AAFD-E26695C01F15 Q38744509-6618B39A-BAC6-46C1-B217-1A4C36B3E1B7 Q38985395-E302F7BC-ED87-498E-9369-6F52F319147E Q39128976-A665A5D3-A7BE-4205-97E8-0C6A09A9F527 Q40035796-B3639E11-6716-400A-9917-3D5E38B8901E Q40093434-11DE33F9-EB40-4136-B6E6-BB455A3AF08A Q40991982-C6679E0D-AFEF-4535-AA52-D21695800DA2 Q44822764-8047F55F-6C72-4537-8562-F532FC3BAAC2 Q47159926-953C7C3B-EDDB-4082-B2B9-1168547D9A78 Q57178844-36153B74-F015-4308-A5AD-2578B5CBD29B

P2860

Multiple sclerosis susceptibility alleles in African Americans.

http://www.wikidata.org/entity/Q33892035

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Multiple sclerosis susceptibility alleles in African Americans.

@ast

Multiple sclerosis susceptibility alleles in African Americans.

@en

type

label

Multiple sclerosis susceptibility alleles in African Americans.

@ast

Multiple sclerosis susceptibility alleles in African Americans.

@en

prefLabel

Multiple sclerosis susceptibility alleles in African Americans.

@ast

Multiple sclerosis susceptibility alleles in African Americans.

@en

P1433

Q33892035-F2A22502-8E72-4380-85C3-085100392DA0

P1476

Q33892035-2A6A1DB6-FBE6-4A2E-9835-6D3F1E8C893D

P2093

Q33892035-0E4CCB94-4DF8-47DF-9BD3-2ED2DB2574F2

Q33892035-121AADDC-F40A-4B9F-9AD8-7E5D324AF84B

Q33892035-164BF9E4-9F20-4B32-BCBB-9E9D081A4CD0

Q33892035-3A9571DB-92A2-4714-9231-F9534291FFE8

Q33892035-3F14B1D3-28E9-4183-8FD3-F0A829B5EF08

Q33892035-60EA3EA6-064C-4CCA-8609-456671865289

Q33892035-723FA374-C3BE-4EFF-BE95-0D482D1B9E40

Q33892035-CB3D30D3-40B6-480C-9DEF-5406CE016D50

Q33892035-D4A9CD98-743F-4363-9558-8C604C87C283

Q33892035-EA242582-36D9-44EC-9F77-50FF1F36C5E5

P2860

Q33892035-0434248B-691C-4C3D-9492-83C3EEE95C06

Q33892035-0BA2871A-CA33-4814-AF9F-8EF10089DE10

Q33892035-0F6EDD83-0CFA-4E00-A788-5F393C7C84DE

Q33892035-0F850765-AB47-4AA7-A0F8-9CC1394F324B

Q33892035-129AD048-3C49-4FC0-8D17-EED2DFF88AEB

Q33892035-1A3B76EC-555C-43EE-BEAF-C06D8C3D4B5F

Q33892035-1C0DD86B-3436-4F3B-B10D-19EC9738148E

Q33892035-1C39328E-EA94-4637-A0F2-878734A4BC3B

Q33892035-1F1AE30C-53F0-4C41-8E54-A4D6C2DA328A

Q33892035-2390AFDA-995D-46A5-A670-DB7BD2B5689A

P2888

Q33892035-F120C855-D5C1-449C-ADCC-E114C92D00BC

P304

Q33892035-6C4DAAAF-56BF-47F2-94A2-7F37BD6F43CC

P31

Q33892035-1918095E-6D16-41BC-BF98-6595285D3C9D

P356

Q33892035-DF7B1AF8-C044-49E7-B49C-5A1DCE8B18D4

P433

Q33892035-25F94F1E-E42A-4CFE-8932-9239F0025DF9

P478

Q33892035-ACBB0385-2B58-42DC-A528-3A8D4DB7FBD2

P50

Q33892035-A9F41F4F-3A2C-42C4-A6F6-66557382BE43

P577

Q33892035-73ECCABB-EBED-4138-AA76-88B88671C066

P5875

Q33892035-1F4115CA-31E6-47DE-8331-7778FDFA69FA

P6179

Q33892035-41D54230-0497-4AED-BF05-F26DB3E62F3D

P698

Q33892035-33DCD61F-8B33-4248-80D3-66CA3DFB77E6

P921

Q33892035-239F5CB2-E81F-4119-9DD5-F455AE4C6CB0

P932

Q33892035-B30542A8-464F-48CF-BC3F-B8C5A63F5D33

P356

P1433

Genes and Immunity

P1476

Multiple sclerosis susceptibility alleles in African Americans

@en

P2093

B A Johnson

http://www.w3.org/2001/XMLSchema#string

B C A Cree

http://www.w3.org/2001/XMLSchema#string

E M Taylor

http://www.w3.org/2001/XMLSchema#string

J Herbert

http://www.w3.org/2001/XMLSchema#string

J R Oksenberg

http://www.w3.org/2001/XMLSchema#string

J Wang

http://www.w3.org/2001/XMLSchema#string

O A Khan

http://www.w3.org/2001/XMLSchema#string

P L De Jager

http://www.w3.org/2001/XMLSchema#string

P-A F Gourraud

http://www.w3.org/2001/XMLSchema#string

S J Caillier

http://www.w3.org/2001/XMLSchema#string

P2860

The prevalence of multiple sclerosis in the world: an update

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Methods for high-density admixture mapping of disease genes

Profound block in thymocyte development in mice lacking p56lck

Rab11-FIP3 and FIP4 interact with Arf6 and the exocyst to control membrane traffic in cytokinesis.

Promotion of neurite extension by protrudin requires its interaction with vesicle-associated membrane protein-associated protein

The FIP3-Rab11 protein complex regulates recycling endosome targeting to the cleavage furrow during late cytokinesis.

Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.

Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis

Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients

P2888

P304

343-350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GENE.2009.81

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38044162

http://www.w3.org/2001/XMLSchema#string

P6179

1016097009

http://www.w3.org/2001/XMLSchema#string

P698

19865102

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

2880217

http://www.w3.org/2001/XMLSchema#string